Xinghai X Li from Torrance, CA, age 61

Xinghai Li Phones & Addresses

Torrance, CA
East Brunswick, NJ
80 Brecknock Ct, Newtown, PA 18940 • (215)4971066
185 Summit Trace Rd, Langhorne, PA 19047 • (215)8601408
Salt Lake City, UT
Wayne, NJ
Buck, PA

Work

Company:

Merck
2007 to 2011
Address:

Rahway, NJ
Position:

Senior research biologist

Education

Degree:

Certificate in Clinical Research Associate
School / High School:

Clinical Research Academy of America
Specialities:

Clinical Research

Skills

In Vitro • Drug Discovery • Cell • Biochemistry • Pharmacology • Clinical Development • In Vivo • Life Sciences • Oncology • Molecular Biology • High Throughput Screening • Animal Models • Cell Biology • Elisa • Cell Based Assays • Immunology • Protein Chemistry • Diabetes • Cell Culture • Biomarkers • Western Blotting • Biomarker Discovery • Rt Pcr • Cancer • Transfection • Genetics • Translational Research • Metabolic Diseases • Signal Transduction • Protein Purification • Therapeutics • Target Identification • Protein Expression • Molecular Pharmacology • Antibodies • Lead Optimization • Hts • Protein Characterization • Qpcr • Gpcrs • Graphpad Prism • Genomics • Translational Medicine • Immunoassays • Enzyme Assays • Flow Cytometry • Cancer Research • Immunoprecipitation • Tissue Culture • Cell Signaling

Industries

Pharmaceuticals

Resumes

Chief Scientific Officer, Co-Founder, Director

view source

Location:

Los Angeles, CA

Industry:

Pharmaceuticals

Work:

Merck - Rahway, NJ 2007 - 2011
Senior Research Biologist
University of Pennsylvania, Diabetes and Endocrine Research Institute - Philadelphia, PA 2002 - 2007
Postdoc at Dr. Morrie Birnbaum's lab
Huntsman Cancer Institute, University of Utah - Salt Lake City 1996 - 2001
PhD Thesis Research at Dr. David Virshup's lab
Sichuan Conti. Ed. College of Med. Sci. - Chengdu, China 1990 - 1995
Assistant Professor

Education:

Clinical Research Academy of America
Certificate in Clinical Research Associate, Clinical Research Luzhou Medical School (5 years)
MD, Medicine University of Pennsylvania
Postdoc training, Diabetes/Metabolism University of Utah
PhD, Molecular/Cellular Biology West China University of Medical Sciences (Sichuan University)
MS, Biochemistry

Skills:

In Vitro
Drug Discovery
Cell
Biochemistry
Pharmacology
Clinical Development
In Vivo
Life Sciences
Oncology
Molecular Biology
High Throughput Screening
Animal Models
Cell Biology
Elisa
Cell Based Assays
Immunology
Protein Chemistry
Diabetes
Cell Culture
Biomarkers
Western Blotting
Biomarker Discovery
Rt Pcr
Cancer
Transfection
Genetics
Translational Research
Metabolic Diseases
Signal Transduction
Protein Purification
Therapeutics
Target Identification
Protein Expression
Molecular Pharmacology
Antibodies
Lead Optimization
Hts
Protein Characterization
Qpcr
Gpcrs
Graphpad Prism
Genomics
Translational Medicine
Immunoassays
Enzyme Assays
Flow Cytometry
Cancer Research
Immunoprecipitation
Tissue Culture
Cell Signaling

Us Patents

Method For Screening Drug-Saccharide Conjugates
view source
US Patent:

20170254798, Sep 7, 2017
Filed:

Mar 4, 2016
Appl. No.:

15/060786
Inventors:

- Rahway NJ, US
Ruojing Yang - Boston MA, US
Xinghai Li - Torrance CA, US
Margaret Wu - Scotch Plains NJ, US
Yuli Chen - Scotch Plains NJ, US
Ge Dai - Edison NJ, US
Songnian Lin - Monroe NJ, US
David E. Kelley - Westfield NJ, US
Mark Erion - Westfield NJ, US
Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:

G01N 33/50
G01N 33/74
Abstract:

Methods for identifying drug-saccharide conjugates that bind the mannose receptor, C type 1, (MRC1) and may be taken up by cells expressing MRC1, and the use of such drug-saccharide conjugates for treatment of particular diseases are described. In particular, the methods for identifying insulin-saccharide conjugates that bind the MRC1 receptor and may be taken up by cells expressing the MRC1 and use of such conjugates for treatment of diabetes are described.

Method For Screening Drug-Saccharide Conjugates
view source
US Patent:

20170248580, Aug 31, 2017
Filed:

May 15, 2017
Appl. No.:

15/595115
Inventors:

- Rahway NJ, US
Ruojing Yang - Boston MA, US
Xinghai Li - Torrance CA, US
Margaret Wu - Scotch Plains NJ, US
Yuli Chen - Scotch Plains NJ, US
Ge Dai - Edison NJ, US
Songnian Lin - Monroe NJ, US
David E. Kelley - Westfield NJ, US
Mark Erion - Westfield NJ, US
Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:

G01N 33/50
G01N 33/569
Abstract:

Methods for identifying drug-saccharide conjugates that bind the mannose receptor, C type 1, (MRC1) and may be taken up by cells expressing MRC1, and the use of such drug-saccharide conjugates for treatment of particular diseases are described. In particular, the methods for identifying insulin-saccharide conjugates that bind the MRC1 receptor and may be taken up by cells expressing the MRC1 and use of such conjugates for treatment of diabetes are described.

Xinghai X Li